Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).

Bertoli S, Bérard E, Peterlin P, Guieze R, Desbrosses Y, Hicheri Y, Benbrahim O, Carre M, Orvain C, Banos A, Bernard M, Gyan E, Saad A, Chebrek S, Guepin GR, Dorvaux V, Sanhes L, Gallego-Hernanz MP, Exbrayat C, Vincent L, Himberlin C, Simand C, Vey N, Fenoll C, Mineur A, Huynh A, Vergez F, Luquet I, Largeaud L, Delabesse E, Pigneux A, Récher C

Open source

DOI
10.3324/haematol.2024.286807
Published
2025 Oct 1
Container
Haematologica
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2024.286807,
  title = {Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).},
  author = {Bertoli S and Bérard E and Peterlin P and Guieze R and Desbrosses Y and Hicheri Y and Benbrahim O and Carre M and Orvain C and Banos A and Bernard M and Gyan E and Saad A and Chebrek S and Guepin GR and Dorvaux V and Sanhes L and Gallego-Hernanz MP and Exbrayat C and Vincent L and Himberlin C and Simand C and Vey N and Fenoll C and Mineur A and Huynh A and Vergez F and Luquet I and Largeaud L and Delabesse E and Pigneux A and Récher C},
  year = {2025},
  journal = {Haematologica},
  doi = {10.3324/haematol.2024.286807},
  url = {https://doi.org/10.3324/haematol.2024.286807}
}

RIS

TY  - JOUR
TI  - Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).
AU  - Bertoli S
AU  - Bérard E
AU  - Peterlin P
AU  - Guieze R
AU  - Desbrosses Y
AU  - Hicheri Y
AU  - Benbrahim O
AU  - Carre M
AU  - Orvain C
AU  - Banos A
AU  - Bernard M
AU  - Gyan E
AU  - Saad A
AU  - Chebrek S
AU  - Guepin GR
AU  - Dorvaux V
AU  - Sanhes L
AU  - Gallego-Hernanz MP
AU  - Exbrayat C
AU  - Vincent L
AU  - Himberlin C
AU  - Simand C
AU  - Vey N
AU  - Fenoll C
AU  - Mineur A
AU  - Huynh A
AU  - Vergez F
AU  - Luquet I
AU  - Largeaud L
AU  - Delabesse E
AU  - Pigneux A
AU  - Récher C
PY  - 2025
JO  - Haematologica
DO  - 10.3324/haematol.2024.286807
UR  - https://doi.org/10.3324/haematol.2024.286807
ER  - 

APA

S, B., E, B., P, P., R, G., Y, D., Y, H., O, B., M, C., C, O., A, B., M, B., E, G., A, S., S, C., GR, G., V, D., L, S., MP, G., C, E., L, V., C, H., C, S., N, V., C, F., A, M., A, H., F, V., I, L., L, L., E, D., A, P., & C, R. (2025). Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).. Haematologica. https://doi.org/10.3324/haematol.2024.286807

Source records